TABLE 1.
Serological IgM and IgG results in the general population and in patients acutely infected with HEV genotype 1 and genotype 3
| Group and test | No. of controls or patients | No. (%) of samples positive for:
|
||
|---|---|---|---|---|
| IgM | IgG | Both IgM and IgG | ||
| Controls | ||||
| ELISA | 167 | 4 (2.4) | 12 (7.2) | 2 (1.2) |
| Blotting | 65 | 2 (3.1) | 22 (33.8) | 2 (3.1) |
| Combineda | 167 | 1 (0.5) | 6 (3.6) | 1 (0.5) |
| Genotype 1 patients | ||||
| ELISA | 8 | 3 (38) | 8 (100) | 3 (38) |
| Blotting | 8 | 8 (100) | 8 (100) | 8 (100) |
| Combineda | 8 | 8 (100) | 8 (100) | 8 (100) |
| Genotype 3 patients | ||||
| ELISA | 16 | 16 (100) | 14 (88) | 14 (88) |
| Blotting | 16 | 14 (88) | 16 (100) | 14 (88) |
| Combineda | 16 | 14 (88) | 16 (100) | 14 (88) |
a
Combined results are from initial screening of samples by ELISA with only positive results confirmed by immunoblotting.